Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD
IQMD was delisted on the 26th of April, 2023.
8 hedge funds and large institutions have $5.26M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 54 closing their positions.
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
87% less funds holding
Funds holding: 60 → 8 (-52)
96% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 54
97% less capital invested
Capital invested by funds: $197M → $5.26M (-$192M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$10.6M |
| 2 |
CS
Clear Street
New York
|
+$179K |
| 3 |
Walleye Capital
New York
|
+$89.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
-$22.3M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$12.8M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$9.48M |
| 4 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$8.22M |
| 5 |
D.E. Shaw & Co
New York
|
-$8.09M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EC
51
Elequin Capital
New York
| – | -$458K | -44,540 | Closed |
|
|
BFM
52
Boothbay Fund Management
New York
| – | -$446K | -43,401 | Closed |
|
|
RL
53
RPO LLC
Stamford,
Connecticut
| – | -$371K | -36,083 | Closed |
|
|
ASM
54
ATW SPAC Management
New York
| – | -$324K | -31,494 | Closed |
|
|
LCM
55
Lynwood Capital Management
Toronto,
Ontario, Canada
| – | -$324K | -31,454 | Closed |
|
|
SAMU
56
SONA Asset Management (US)
New York
| – | -$308K | -30,000 | Closed |
|
|
COPPSERS
57
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| – | -$257K | -25,000 | Closed |
|
|
DCM
58
Dupont Capital Management
Wilmington,
Delaware
| – | -$257K | -25,000 | Closed |
|
|
PP
59
Paloma Partners
Greenwich,
Connecticut
| – | -$205K | -20,000 | Closed |
|
60
Capstone Investment Advisors
New York
| – | -$103K | -10,000 | Closed |
|
61
UBS Group
Zurich,
Switzerland
| – | -$15.5K | -1,504 | Closed |
|
|
QL
62
Quarry LP
New York
| – | -$7.82K | -761 | Closed |
|
IQMD Hedge Fund Activity: Q1 2023 in Review
8 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q1 2023, worth a combined $5.26M — down 97% from $197M a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of IQMD and 2 opened new positions — a net loss of 52 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $10.6M. The largest seller was Saba Capital Management, exiting entirely with an estimated $22.3M sold.
- 8 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q1 2023, down from 60 in Q4 2022.
- Funds reported $5.26M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q1 2023, down 97% quarter-over-quarter.
- 2 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q1 2023 and 54 closed out, a net change of -52 holders.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q1 2023 was Cantor Fitzgerald, an estimated $10.6M added.
- The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q1 2023 was Saba Capital Management, an estimated $22.3M sold.
Based on aggregated 13F filings for Q1 2023.